NUVILEX, INC.

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

General form for quarterly reports under Section 13 or 15(d)

Annual Report Scanned (Paper)

Definitive Proxy Statement

Preliminary Proxy Statement

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Financial Statements and Exhibits

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Definitive Proxy Statement

Notice of Effectiveness

Correspondence with the SEC

Preliminary Proxy Statement

Letter from the SEC

Registration statement under Securities Act of 1933

General form for quarterly reports under Section 13 or 15(d)

Entry into a Material Definitive Agreement

Rule 506(b) provides a "safer harbor" for a private offering

Entry into a Material Definitive Agreement

Annual report pursuant to Section 13 or 15(d)

Notification of late filing of Form 10-K

Submission of Matters to a Vote of Security Holders

General form for quarterly reports under Section 13 or 15(d)

Annual Report Scanned (Paper)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Changes in Registrant's Certifying Accountant

General form for quarterly reports under Section 13 or 15(d)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Annual report pursuant to Section 13 or 15(d)

Notification of late filing of Form 10-K

1.01,2.01,8.01,9.01

5.07

Annual Report Scanned (Paper)

Definitive Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

5.02

1.01,8.01,9.01

4.01

Notice of Effectiveness

Correspondence with the SEC

Registration statement under Securities Act of 1933 (amendment)

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Registration statement under Securities Act of 1933 (amendment)

5.03,5.07,9.01

4.01,9.01

Correspondence with the SEC

Registration statement under Securities Act of 1933 (amendment)

Annual report pursuant to Section 13 or 15(d)

Definitive Proxy Statement

5.03,8.01,9.01

Preliminary Proxy Statement

Letter from the SEC

Registration statement under Securities Act of 1933

Correspondence with the SEC

Definitive Proxy Statement

Correspondence with the SEC

Preliminary Proxy Statement

Letter from the SEC

1.01,3.02,5.03,5.07,8.01,9.01

General form for quarterly reports under Section 13 or 15(d)

8.01,9.01

5.07

Definitive Proxy Statement

5.02,5.03,9.01

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional proxy soliciting materials filed by a non-management party

Additional Information for Proxy Statement/ Votes

No description available

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Letter from the SEC

Correspondence with the SEC

Registration statement under Securities Act of 1933

06b

Prospectus Supplement for Primary Offering

No description available

Prospectus Supplement for Primary Offering

Certification of approval for listing and registration on a national securities exchange

Prospectus Supplement for Primary Offering

Registration of Securities on Exchange

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

SCHECHTER JONATHAN

WEINSTEIN ROBERT

WALKER WAYNE REMELL

Abecassis Michael M

SCHECHTER JONATHAN

WEINSTEIN ROBERT

WALKER WAYNE REMELL

Abecassis Michael M

PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc.

SCHECHTER JONATHAN

Silverman Joshua

WEINSTEIN ROBERT

Abecassis Michael M

SCHECHTER JONATHAN

Silverman Joshua

WALKER WAYNE REMELL